Search
Menu
Sheetak -  Cooling at your Fingertip 11/24 LB

FDA Approves LaserSight's LSX for Myopic Astigmatism

Facebook X LinkedIn Email
WINTER PARK, Fla., Oct. 3 -- LaserSight Inc. said that the FDA has approved its LaserScan LSX precision microspot scanning excimer laser system for the LASIK treatment of myopia (nearsightedness) with and without astigmatism. The approval is for a range of treatment of refractive errors up to -6.00 diopters manifest refraction spherical equivalent (MRSE) with or without a refractive astigmatism up to 4.5 diopters of cylinder. The range of spherical equivalent approved for treatment is reported to address approximately 85 percent of the myopic patients currently applying for refractive...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: October 2001
    News & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.